Navigation Links
New Study Shows the Use of MEDIHONEY(TM) Wound & Burn Dressing is Associated With Reduction in Wound Size
Date:4/8/2008

uka honey dressings was associated with a statistically significant decrease in wound pH and a reduction in wound size." Significant wound progression during a two-week period is noted as a strong predictor of good wound healing outcomes.

Commenting on the article, Derma Sciences CEO Edward Quilty said, "Method of action is obviously an important component to having a better understanding of a medical device. Based on the results clinicians have seen all over the world, and recently here since our launch in the US and Canada, we have known for quite some time that the dressings work. Now we are getting a better understanding as to 'why'. Providing the answer to this question will no doubt increase product usage, as it makes clinicians feel more comfortable that the product has been studied thoroughly, it is effective, and we understand why it is effective. Although pH modulation and the product's high osmolarity have long been thought to contribute to the effectiveness of the product, it is rewarding to see these beliefs are being confirmed through good, well structured trials."

He also added, "This is yet another important study focused on non-healing or recalcitrant wounds that are not progressing with other advanced wound care modalities. It will only help to improve MEDIHONEY(TM)'s growing reputation as an effective dressing to 'kick-start' the healing process. This is what clinicians are reporting to us after their lengthy clinical evaluations. As we planned, we believe clinicians are gaining significant confidence in our dressing for very troublesome wounds. Once this is established in the market, it then becomes only a matter of time before the dressing is more commonly used even from the onset of a wound. This will be reflected in growing product sales as we ramp up throughout 2008 and into 2009."

About Derma Sciences

Derma Sciences is a manufacturer and marketer of advanced wound-care products, with operations based in the US and
'/>"/>

SOURCE Derma Sciences Inc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Study Shows the Personal Touch Is Key to Maintaining Weight Loss
2. Medical errors cost US $8.8B, result in 238,337 potentially preventable deaths: HealthGrades study
3. ASCRS to participate in and co-fund study on post-lasik quality of life with US FDA
4. New study finds adverse effects of estrogen replacement therapy are related to the dose
5. Geisinger study: Use of digital health records improve health of the elderly
6. Occupational therapists use Wii for Parkinsons study
7. Preliminary Data From Pitt County Memorial Hospital Study Show Benefit of Active Surveillance on Reducing MRSA VAP Rates in Surgical ICU
8. Animal Study Links Social Standing With Drug Use Risk
9. Study Shows Anger Has Its Uses
10. 1st US study -- gymnastics lands thousands in ER
11. Study finds economic burden of health insurance increasing for small employers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... WASHINGTON, Nov. 20 Th...ed the Senate to make essential changes its health... on abortion funding and conscience protection on ...ants and include strong provisions for adequate af...ealth care bill an "enormous disappointment" that ...
(Date:11/20/2009)...AGO, Nov. 20 The Americ...ood and Drug Administration (FDA) to establish app...cals. ,, Citing concern about the safety of wh...ut the benefit of professional consultation or exa...he application of chemically based tooth whitening...
(Date:11/20/2009)...EGAS, Nov. 20 The follo...rector of the Nevada Health Care Association: ,...nds and thanks Senate Majority Leader Harry Reid f...er toward our goal of protecting every Nevada seni...and preserving the strength and viability of our s...
(Date:11/20/2009)...essure readings in children with chronic kidney di...ng doctor,s office visits increasing a child,s ri...ch from Johns Hopkins Children,s Center and other ...ine in the Journal of American Society of Nephrolo...urements obtained during regular doctor visits to ...
(Date:11/20/2009)...up to one-third buying 90-day supply, study finds ...Buying a three-month supply of prescription drugs ... supply, according to a new study. , U.S. resea...5 drugs between 2000 and 2005, and found that pati...one-month supply saved an average 29 percent in ou...
Breaking Medicine News(10 mins):Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:High blood pressure easy to miss in children with kidney disease 2Health News:Three-Month Supply Lowers Drug Costs 2
...d the registration, production and marketing right...tre for Biotechnology in the Jawaharlal Nehru Univ...d be in the market in 3-4 months. The Company has ...ake any projections on the business the vaccine is...
...d the code for the bacterium that causes the poten...ilis.The discovery could pave the way for a preven...ments.// Syphilis once caused widespread epid... can be treated with injections of penicillin or o...
...linking childhood sexual abuse and schizophrenia w.... According to a research in the American Journal,...n the study// were victims of sexual abuse. The pr...factor. But World Schizophrenia Fellowship head Ji...
...ay to quash allergy symptoms may work better than ...d on an "as-needed'', rather than daily basis, the...rgy symptoms such as runny nose, sneezing and cong...y reducing the inflammation that occurs in the nos...
...the appropriate treatment should be recommended fo...he complications. Women who have// had breast canc...ho have chemotherapy and tamoxifen may have reduce...ors of breast cancer. They find that these women, ...
...racterised by a sudden excruciating pain on one si...nd can last for 20 minutes to 4 hours. Affecting 0...er a period of weeks or months before disappearing...proaches to all primary headaches, which had not b...
Other Medicine News:
(Date:11/19/2009)...BIRMINGHAM, Ala., Nov. 19 /PRNewswire-FirstCall/ -...today announced the pricing of a public offering o...r share, resulting in gross proceeds of $48.75 mil...ryst pursuant to an effective shelf registration s...Exchange Commission. BioCryst has also granted th...
(Date:11/19/2009)...UNTAIN VIEW, Calif., Nov. 19 /PRNewswire-FirstCall... announced today that its corporate presentation w...affray Health Care Conference on Wednesday, Decemb...ation will be webcast from The New York Palace Hot...King, Alexza President and CEO. ,, To access ...
(Date:11/19/2009)... NEW YORK, Nov. 19 As the seasons ... is here. Here,s more on preparing yourself. ,,...harmaceuticals Inc. at: ,, http://inr.medias...XAOIF ,, Medialink is a division of The News...audio, text, graphics and photos at http://www.t...
Breaking Medicine Technology:BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Finalists Perform at Rock Hall in Rainbow Babies 26 Childrens Hospitals Pause to Click Contest Encouraging Safety Belt Use for Tweens 47977 1Finalists Perform at Rock Hall in Rainbow Babies 26 Childrens Hospitals Pause to Click Contest Encouraging Safety Belt Use for Tweens 47977 2President of PRN Funding Appointed to Factoring Association Advisory Board 47974 1President of PRN Funding Appointed to Factoring Association Advisory Board 47974 2Improving livestock productivity in Honduras 8728 1Improving livestock productivity in Honduras 8728 2Improving livestock productivity in Honduras 8728 3
...ence Call to be Held at 9:00 a.m. Eastern Time Tod...United Therapeutics Corporation (Nasdaq: UTHR ) ...ug Administration (FDA) has approved ADCIRCA(TM) (... recommended dose of 40 mg, as the first once-dail...e treatment of pulmonary arterial hypertension (PA...
...LIS, Md., May 22 PharmAthene, Inc. (NYSE Amex: ...ountermeasures against biological and chemical thr...ed its comprehensive regulatory strategy to the U....e non-clinical and clinical development plans for ...inant protective antigen anthrax vaccine. , , The...
Other Medicine Technology:FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 2FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 3FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension 4PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA 2PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA 3PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA 4
...unctional microplate detection system, ,offers the...romising flexibility. ,The Ultra Evolution is Te...atform. New features are available as options whic...nt along with possible upgrade paths should your n...
...roplate based multi-detection reader which incorpo...uorescence Polarization , Fluorescence Intensity ...uminescence (flash and glow) , Absorbance ,It ...adioactive labeled applications:, , Ca2+ Measureme...
...e reader that offers four different measurement mo...e-resolved fluorescence, high-perfomance luminesce...ipped with injectors that deliver reagent at the p...ys can be performed easily and allowing the unit t...
ViewLux ultraHTS Microplate Imager
Medicine Products: